Insider Transactions in Q4 2022 at Surmodics Inc (SRDX)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2022
|
Ronald B Sr Kalich |
BUY
Grant, award, or other acquisition
|
Direct |
523
+1.67%
|
$17,782
$34.12 P/Share
|
|
Nov 30
2022
|
Timothy J. Arens Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,196
+9.35%
|
-
|
|
Nov 30
2022
|
Timothy J. Arens Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,342
-1.06%
|
$48,312
$36.13 P/Share
|
|
Nov 30
2022
|
Gary R Maharaj President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
24,356
+12.4%
|
-
|
|
Nov 30
2022
|
Gary R Maharaj President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,407
-1.78%
|
$194,652
$36.13 P/Share
|
|
Nov 30
2022
|
John D. Manders VP Finance, Corp. Controller |
BUY
Grant, award, or other acquisition
|
Direct |
2,075
+23.41%
|
-
|
|
Nov 30
2022
|
John D. Manders VP Finance, Corp. Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
244
-2.49%
|
$8,784
$36.13 P/Share
|
|
Nov 30
2022
|
Charles W Olson SVP, Medical Device Coatings |
BUY
Grant, award, or other acquisition
|
Direct |
5,535
+10.72%
|
-
|
|
Nov 30
2022
|
Charles W Olson SVP, Medical Device Coatings |
SELL
Payment of exercise price or tax liability
|
Direct |
1,342
-1.61%
|
$48,312
$36.13 P/Share
|
|
Nov 30
2022
|
Teri Woodwick Sides SVP, Vascular Interventions |
BUY
Grant, award, or other acquisition
|
Direct |
8,303
+22.86%
|
-
|
|
Nov 30
2022
|
Teri Woodwick Sides SVP, Vascular Interventions |
SELL
Payment of exercise price or tax liability
|
Direct |
902
-2.21%
|
$32,472
$36.13 P/Share
|
|
Nov 30
2022
|
Joseph J. Stich SVP of HR, President IVD |
BUY
Grant, award, or other acquisition
|
Direct |
5,535
+9.24%
|
-
|
|
Nov 30
2022
|
Joseph J. Stich SVP of HR, President IVD |
SELL
Payment of exercise price or tax liability
|
Direct |
1,449
-1.45%
|
$52,164
$36.13 P/Share
|
|
Nov 30
2022
|
Gordon S. Weber Sr. VP of Legal, GC and Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
5,535
+25.61%
|
-
|
|
Nov 30
2022
|
Gordon S. Weber Sr. VP of Legal, GC and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
902
-4.13%
|
$32,472
$36.13 P/Share
|
|
Nov 28
2022
|
Jose H Bedoya |
SELL
Open market or private sale
|
Direct |
4,366
-15.29%
|
$148,444
$34.89 P/Share
|
|
Nov 28
2022
|
Jose H Bedoya |
BUY
Exercise of conversion of derivative security
|
Direct |
4,366
+13.26%
|
$87,320
$20.18 P/Share
|
|
Nov 25
2022
|
Charles W Olson SVP, Medical Device Coatings |
SELL
Payment of exercise price or tax liability
|
Direct |
471
-1.11%
|
$16,956
$36.02 P/Share
|
|
Nov 25
2022
|
Timothy J. Arens Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
543
-0.84%
|
$19,548
$36.02 P/Share
|
|
Nov 25
2022
|
Joseph J. Stich SVP of HR, President IVD |
SELL
Payment of exercise price or tax liability
|
Direct |
586
-1.15%
|
$21,096
$36.02 P/Share
|
|
Nov 25
2022
|
Gary R Maharaj President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,172
-1.4%
|
$78,192
$36.02 P/Share
|
|
Nov 25
2022
|
John D. Manders VP Finance, Corp. Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
61
-1.22%
|
$2,196
$36.02 P/Share
|
|
Nov 25
2022
|
Teri Woodwick Sides SVP, Vascular Interventions |
SELL
Payment of exercise price or tax liability
|
Direct |
365
-1.74%
|
$13,140
$36.02 P/Share
|
|
Nov 14
2022
|
David Dantzker |
SELL
Open market or private sale
|
Direct |
2,773
-7.5%
|
$91,509
$33.0 P/Share
|
|
Nov 14
2022
|
David Dantzker |
BUY
Exercise of conversion of derivative security
|
Direct |
4,366
+10.57%
|
$87,320
$20.18 P/Share
|
|
Nov 11
2022
|
Ronald B Sr Kalich |
SELL
Open market or private sale
|
Direct |
2,733
-8.3%
|
$90,189
$33.48 P/Share
|
|
Nov 11
2022
|
Ronald B Sr Kalich |
BUY
Exercise of conversion of derivative security
|
Direct |
4,366
+11.71%
|
$87,320
$20.18 P/Share
|